Free Trial

Vitalhub (TSE:VHI) Given New C$14.50 Price Target at Scotiabank

Vitalhub logo with Medical background

Vitalhub (TSE:VHI - Get Free Report) had its target price hoisted by equities researchers at Scotiabank from C$14.00 to C$14.50 in a note issued to investors on Friday,BayStreet.CA reports. The firm presently has an "outperform" rating on the stock. Scotiabank's target price indicates a potential upside of 29.93% from the company's previous close.

A number of other research firms have also weighed in on VHI. TD Securities upped their price objective on Vitalhub from C$13.00 to C$14.00 and gave the stock a "buy" rating in a research note on Monday, March 31st. Raymond James Financial set a C$13.50 price target on Vitalhub and gave the stock an "outperform" rating in a research note on Thursday, March 27th. National Bankshares set a C$14.00 price objective on shares of Vitalhub and gave the company an "outperform" rating in a research report on Tuesday, June 10th. Finally, National Bank Financial raised shares of Vitalhub to a "strong-buy" rating in a report on Monday, June 9th. Six analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Buy" and an average target price of C$13.25.

Get Our Latest Report on VHI

Vitalhub Price Performance

Shares of TSE:VHI traded up C$0.11 during midday trading on Friday, hitting C$11.16. The company had a trading volume of 33,326 shares, compared to its average volume of 127,448. The company has a market cap of C$603.67 million, a price-to-earnings ratio of 181.51, a PEG ratio of 1.18 and a beta of 1.26. The company has a fifty day moving average of C$10.58 and a two-hundred day moving average of C$10.63. Vitalhub has a 12-month low of C$6.74 and a 12-month high of C$12.34.

Insider Buying and Selling at Vitalhub

In other Vitalhub news, Director Francis Nelson Shen purchased 25,000 shares of the stock in a transaction on Friday, May 16th. The shares were bought at an average cost of C$10.23 per share, with a total value of C$255,750.00. 18.57% of the stock is currently owned by company insiders.

Vitalhub Company Profile

(Get Free Report)

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.

See Also

Analyst Recommendations for Vitalhub (TSE:VHI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Vitalhub Right Now?

Before you consider Vitalhub, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.

While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now
Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines